Substance Misuse Programs in Commercial Aviation: Safety First (2023)
Chapter: Appendix B: Speakers, Papers, and Literature Review - Data Gathering
Appendix B
Speakers, Papers, and Literature Review—Data Gathering
SPEAKERS (BY DATE OF PRESENTATION)
June 30, 2022
The lead liaison staff from the Federal Aviation Administration (FAA): Penny Giovanetti, Office of Aerospace Medicine; Tom Cuddy, Systems and Policy Analysis Division; and Phil Putter, Office of Aviation Policy and Plans. These speakers gave an overview of their priorities.
Quay Snyder, program manager of the Human Intervention and Motivational Study (HIMS). Provided an overview of HIMS.
Heather Healy, manager of the Flight Attendant Drug and Alcohol Program (FADAP). Provided an overview of FADAP.
August 22, 2022
Nora Volkow, director of the National Institute on Drug Abuse and a recognized expert on addictions and their treatment.
Thomas McLellan, former deputy director of the Office of National Drug Control Policy, editor of the Surgeon General’s Report on Alcohol and Drugs (HHS, 2016), and lead researcher on an evaluation of 16 physician health programs that serve physicians with substance abuse disorders (McLellan et al., 2008).
Ted Trippi, legislative assistant for U.S. Senator Jeanne Shaheen of New Hampshire. Provided background on the study’s origins and congressional expectations.
November 1, 2022
Gary Kay, chief scientific officer, Cognitive Research Corporation. Gave a presentation, related to his commissioned paper, on aviation issues around impairment, cognition, and treatment.
Sarah Polk, SkyWest Airlines; and Dave St. Hilaire, Allegiant Airlines. Presented the flight attendants’ perspective, as both are active in their respective FADAP organizations.
Captain Dave Fielding, British Airways. Gave a presentation on pilot well-being and peer support systems and offered an international perspective.
Andrew LeBovidge, executive vice president, National Air Traffic Controllers Association; Pat Moy, manager of drug abatement and regulatory compliance, United Airlines; and Kip Bowen, senior manager, Employee Assistance Program, United Airlines. All participated in a panel assessing existing support systems across aviation.
COMMISSIONED AUTHORS AND THEIR PAPERS
The papers listed here were all commissioned for the Study and Recommendations on the HIMS, FADAP, and Other Drug and Alcohol Programs within the U.S. Department of Transportation (DOT) by the Board on Behavioral, Cognitive, and Sensory Sciences, National Academies of Sciences, Engineering, and Medicine, Washington, DC.1
Gary Kay and Heather Belanger
Commissioned paper: Impairment Effects: Pharmacotherapies for Alcohol Use Disorder (AUD) and Opioid Use Disorder (OUD) Treatment (2022)
Cara Nordberg
Commissioned paper: Analysis of FADAP Database (2022)
Jennifer Wisdom
Commissioned paper: Call for Perspectives and Qualitative Interview Analysis (2022)
___________________
1 See the commissioned paper tab at https://nap.nationalacademies.org/catalog/27025/substance-misuse-programs-in-commercial-aviation-safety-first
MATERIALS REVIEWED FOR LITERATURE SEARCH
The National Academies of Sciences Research Center compiled two literature reviews for the study. The first focused on whether any previous research existed on HIMS and FADAP, along with material describing the structure or effectiveness of other substance-abuse-related programs (non-HIMS/FADAP) within the FAA or DOT.2 The second examined the wider mental health and well-being of pilots, flight attendants, and other transportation industry employees.
___________________
2 Additional information for Appendix A was provided by Jerry Powers, Office of Railroad Safety, Federal Railroad Administration; Iyon Rosario, Office of Safety & Oversight, Federal Transit Administration; and Bryan Price, Drug & Alcohol Program Division, Federal Motor Carriers Safety Administration.
This page intentionally left blank.
